BioXcel Therapeutics, Inc.
USD1.40
+0.09 (+6.87%)
CEO
Vimal D. Mehta
IPO Date
2018-03-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.28
Prev. Close
$1.31
Day Low
$1.28
Day High
$1.46
52W Low
$1.01
52W High
$8.08
Market Cap
$0.04B
Volume
1.10M
| 35 |
| $0.00 |
| 17 Jun 2026 | Steinhart Richard I | Chief Financial Officer | M-Exempt | Acquired | 35 | $0.00 |
| 17 Jun 2026 | Steinhart Richard I | Chief Financial Officer | M-Exempt | Disposed | 35 | $0.00 |
| 17 Jun 2026 | Yocca Frank | Chief Scientific Officer | M-Exempt | Acquired | 35 | $0.00 |
| 17 Jun 2026 | Yocca Frank | Chief Scientific Officer | M-Exempt | Disposed | 35 | $0.00 |
| 17 Jun 2026 | Mehta Vimal | director, officer: CEO and President | M-Exempt | Acquired | 219 | $0.00 |
| 17 Jun 2026 | Mehta Vimal | director, officer: CEO and President | M-Exempt | Disposed | 219 | $0.00 |
| 22 May 2026 | Yocca Frank | Chief Scientific Officer | M-Exempt | Acquired | 17,500 | $0.00 |
| 22 May 2026 | Yocca Frank | Chief Scientific Officer | S-Sale | Disposed | 6,845 | $1.08 |